Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes

Aims. Insulin degludec (IDeg) is a novel insulin analogue that, following subcutaneous injection, forms soluble multihexamers, resulting in an ultra-long duration of action, which is two-fold longer than that of insulin glargine (IGlar). We present data from Russian cohorts of two multinational, ope...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina Vladimirovna Shestakova, Michail Vladimirovich Antciferov, Alexander Yur'evich Mayorov, Luydmila Alexandrovna Ruyatkina, Ludmila Alexandrovna Suplotova, Sergey Anatol'evich Dogadin, Nikolay Borisovich Lebedev, Yana Gennadievna Alekseeva
Format: article
Language:EN
RU
Published: Endocrinology Research Centre 2015
Subjects:
diabetes mellitus
glycaemic control
insulin analogues
insulin therapy
the phase 3 study
Nutritional diseases. Deficiency diseases
RC620-627
Online Access:https://doaj.org/article/addf81b97bd5452b82b135e445ce89a8
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items